NRX Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| B GROUP, INC. | 05/15/2026 | 3.00 M | $6.39 M | 100.00% | 14.02% |
| 05/15/2026 | 1.16 M | $2.47 M | 100.00% | 5.42% | |
| ADVISORSHARES INVESTMENTS LLC | 04/28/2026 | 420.47 K | $895.60 K | 28.19% | 1.96% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 397.43 K | $846.53 K | 8.40% | 1.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 310.11 K | $660.61 K | 41.69% | 1.45% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 169.58 K | $361.21 K | 100.00% | 0.79% |
| BLEAKLEY FINANCIAL GROUP, LLC | 05/04/2026 | 117.20 K | $249.65 K | 0.00% | 0.55% |
| JANE STREET GROUP, LLC | 05/12/2026 | 99.90 K | $212.79 K | 100.00% | 0.47% |
| BLACKROCK, INC. | 05/13/2026 | 99.00 K | $210.86 K | 19.77% | 0.46% |
| STATE STREET CORP | 05/15/2026 | 86.98 K | $185.28 K | 0.00% | 0.41% |
| XTX TOPCO LTD | 05/15/2026 | 78.73 K | $167.70 K | 100.00% | 0.37% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 69.70 K | $148.46 K | 150.72% | 0.33% |
| JANE STREET GROUP, LLC | 05/12/2026 | 44.15 K | $94.04 K | 15.99% | 0.21% |
| NORTHERN TRUST CORP | 05/14/2026 | 43.47 K | $92.59 K | 50.17% | 0.20% |
| HEADLANDS TECHNOLOGIES LLC | 05/13/2026 | 39.39 K | $83.91 K | 100.00% | 0.18% |
| JANE STREET GROUP, LLC | 05/12/2026 | 36.60 K | $77.96 K | 19.61% | 0.17% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 05/04/2026 | 34.48 K | $102.40 K | 3.17% | 0.16% |
| AXQ CAPITAL, LP | 05/13/2026 | 33.21 K | $70.74 K | 100.00% | 0.16% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 32.50 K | $69.23 K | 100.00% | 0.15% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 31.79 K | $68.00 K | 100.00% | 0.15% |
| UBS GROUP AG | 05/05/2026 | 25.23 K | $53.73 K | 613.03% | 0.12% |
| CITADEL ADVISORS LLC | 05/15/2026 | 24.70 K | $52.61 K | -31.01% | 0.12% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 19.88 K | $42.34 K | 100.00% | 0.09% |
| ETHOS FINANCIAL GROUP, LLC | 05/05/2026 | 15.90 K | $33.87 K | 33.61% | 0.07% |
| 04/13/2026 | 15.00 K | $31.95 K | 0.00% | 0.07% | |
| MORGAN STANLEY | 05/15/2026 | 10.03 K | $21.36 K | -0.01% | 0.05% |
| ROYAL BANK OF CANADA | 05/15/2026 | 2.51 K | $5.00 K | 25.45% | 0.01% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 2.50 K | $5.33 K | 0.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 2.35 K | $5.01 K | 17.50% | 0.01% |
| CLEAR STREET MARKETS LLC | 04/30/2026 | 1.14 K | $2.42 K | 100.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 737 | $1.57 K | 100.00% | 0.00% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 05/04/2026 | 500 | $1.49 K | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 90 | $191 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 81 | $173 | 8,000.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 34 | $71 | 0.00% | 0.00% |
| LARSON FINANCIAL GROUP LLC | 05/15/2026 | 22 | $47 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 1 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| ANSON FUNDS MANAGEMENT LP | 05/19/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
NRX Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of NRX Pharmaceuticals Inc. The most heavily invested institutionals were:
B Group, Inc.: 3 M
AdvisorShares Investments LLC: 420,467
COMMONWEALTH EQUITY SERVICES, LLC: 397,431
GEODE CAPITAL MANAGEMENT, LLC: 310,112
VANGUARD FIDUCIARY TRUST CO: 169,580
Bleakley Financial Group, LLC: 117,204
28.79% of NRX Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.03 M shares in the last 24 months. This purchase volume represents approximately $10.43 M in transactions.